SPONSORED CONTENT
The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug
…SPONSORED CONTENT
Please join on us October 8th at 2pm EST for our second installment of RxParadigm’s 340B Clearinghouse Webinar Series.
As the 340B landscape continues to shift, it is time for action to deliver consistency and sustainability and a 340B future that
…
Q: Tell us some interesting details about your company’s history.
RxParadigm, founded by industry veteran Mesfin Tegenu, is dedicated to developing technology solutions that streamline the drug supply chain and
…
Q: Where did you grow up?
I grew up in Addis Ababa, the capital city of Ethiopia.
Q: Where did you go to college/graduate school?
I completed my undergraduate studies at Addis Ababa University in Ethiopia and attended graduate school at St. John’s University in Queens, New York.
Q: What are your favorites?
Food: I mostly enjoy
…
SPONSORED CONTENT
The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program provides safety net providers with critical resources necessary to expand health related services to low-income and uninsured individuals. Over the past decade, controversy,
…*Sign up for news summaries and alerts from 340B Report
